Yubo International Biotech Limited (YBGJ)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 68.23 Thousand | -1.02 Million | 101.1 Thousand | -32 Thousand | -55 Thousand | -55 Thousand |
| Net Income | -1.2 Million | -1.54 Million | -711.8 Thousand | -148 Thousand | -144 Thousand | -224 Thousand |
| Depreciation & Amortization | 27.53 Thousand | 21.4 Thousand | 13.06 Thousand | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.24 Million | 492.49 Thousand | 799.84 Thousand | -148 Thousand | -144 Thousand | -114 Thousand |
| Other non-cash items | - | 7683.00 | - | 264 Thousand | 233 Thousand | 283 Thousand |
| Investing Cash Flow | -39.77 Thousand | -564.71 Thousand | -97.46 Thousand | - | - | - |
| Investments in PPE | -39.77 Thousand | -564.71 Thousand | -97.46 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | 127.16 Thousand | 1.38 Million | 34 Thousand | 56 Thousand | 45 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 750 Thousand | - | - | - |
| Other Financing Activities | - | 127.16 Thousand | 634.75 Thousand | 34 Thousand | 56 Thousand | 45 Thousand |
| Accounts receivables | 110.02 Thousand | -159.64 Thousand | -2316.00 | - | - | - |
| Accounts payables | 274 Thousand | 174.65 Thousand | 101.17 Thousand | 116 Thousand | 89 Thousand | 169 Thousand |
| Inventory | -157.87 Thousand | -97.15 Thousand | -67.14 Thousand | - | - | - |
| Other working capital | 1.01 Million | 574.63 Thousand | 768.13 Thousand | -264 Thousand | -233 Thousand | -283 Thousand |
| Cash at beginning of period | 27.51 Thousand | 1.38 Million | 1262.00 | 2000.00 | 1000.00 | 11 Thousand |
| Cash at end of period | 18.22 Thousand | 27.51 Thousand | 1.38 Million | 4000.00 | 2000.00 | 1000.00 |
| Capital Expenditure | -39.77 Thousand | -564.71 Thousand | -97.46 Thousand | - | - | - |
| Effect of forex changes on cash | -37.75 Thousand | 103.4 Thousand | -7133.00 | - | - | - |
| Net cash flow / Change in cash | -9297.00 | -1.35 Million | 1.38 Million | 2000.00 | 1000.00 | -10 Thousand |
| Free Cash Flow | 28.46 Thousand | -1.58 Million | 3639.00 | -32 Thousand | -55 Thousand | -55 Thousand |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -367.32 Thousand | -316.66 Thousand | 103.6 Thousand | -1.2 Million | -238.09 Thousand | -491.55 Thousand |
| Depreciation & Amortization | 18.32 Thousand | 9559.00 | 11.39 Thousand | 27.53 Thousand | 5276.00 | 5284.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 196.08 Thousand | 274.43 Thousand | -135.35 Thousand | 1.24 Million | 288.05 Thousand | 515.72 Thousand |
| Other non-cash items | - | - | - | - | - | -47.07 Thousand |
| Investing Cash Flow | - | - | - | -39.77 Thousand | -39.77 Thousand | 9611.00 |
| Investments in PPE | - | - | - | -39.77 Thousand | - | 9611.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -39.77 Thousand | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 8822.00 | -6290.00 | -3470.00 | 110.02 Thousand | 96.75 Thousand | 54.71 Thousand |
| Accounts payables | 27.03 Thousand | -168.65 Thousand | -134.21 Thousand | 274 Thousand | -4836.00 | 294.18 Thousand |
| Inventory | 12.52 Thousand | 97.54 Thousand | -191.62 Thousand | -157.87 Thousand | 11.36 Thousand | 10.93 Thousand |
| Other working capital | 147.69 Thousand | 351.83 Thousand | 193.95 Thousand | 1.01 Million | 184.77 Thousand | 155.89 Thousand |
| Cash at beginning of period | 30.23 Thousand | 18.22 Thousand | 89.96 Thousand | 27.51 Thousand | 36.58 Thousand | 10.43 Thousand |
| Cash at end of period | 5298.00 | 30.23 Thousand | 18.22 Thousand | 18.22 Thousand | 89.96 Thousand | 36.58 Thousand |
| Capital Expenditure | - | - | - | -39.77 Thousand | - | 9611.00 |
| Effect of forex changes on cash | 127.99 Thousand | 44.67 Thousand | -51.4 Thousand | -37.75 Thousand | 37.92 Thousand | 34.16 Thousand |
| Net cash flow / Change in cash | -24.93 Thousand | 12.01 Thousand | -71.74 Thousand | -9297.00 | 53.38 Thousand | 26.14 Thousand |
| Free Cash Flow | -152.92 Thousand | -32.66 Thousand | -20.34 Thousand | 28.46 Thousand | 55.23 Thousand | -8017.00 |
PRRSF
DCBO
TCLCONS
FMX
BEI-UN
MSON-B